Updates are available Correction dated 2023-05-29

Article History

Received: 22 October 2022

Accepted: 31 January 2023

First Online: 20 February 2023

Change Date: 29 May 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00592-023-02117-9

Declarations

:

: Edoardo Mannucci has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis, and research grants from Merck, Novartis, and Takeda. Ilaria Dicembrini has received speaking fees from Merck, Novo Nordisk, Eli Lilly, Abbott, Sanofi, and Boehringer Ingelheim. Valdo Ricca received fees from agencies for speaking in symposia sponsored by Angelini, Janssen, Lundbeck, Otsuka. Cosentino Claudia, Rossi Eleonora, Pala Laura, Lelmi Romina, Chiara Campanino, Francesco Rotella declare no conflict of interest to disclose.

: The study was approved by the Florence Ethical Board (approval number CEAVC 17044_oss/2020).